Insurers navigate risk of two-thirds weight regain with GLP-1 medications: Swiss Re
Reinsurance News - Apr 16, 2025
Insurance companies face a growing challenge as they adapt to the rise of GLP-1 receptor agonists, such as Ozempic and Wegovy, which have proven effective in managing weight and improving obesity-related health conditions. Swiss Re, a provider of reinsurance and insurance solutions, highlights the i...
Recommended Articles
Posted: Apr 01, 2026
In a letter to shareholders accompanying AIG’s annual report, chairman and CEO Peter Zaffino emphasi...
Posted: Apr 01, 2026
AM Specialty Insurance Group (ASIG), a provider of specialty insurance solutions, has announced a se...
Posted: Apr 01, 2026
Acrisure, a global fintech leader, has completed its previously announced acquisition of specialty r...